93 related articles for article (PubMed ID: 15385943)
1. Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
Lefrère F; Lévy V; François S; Delarue R; Ifrah N; Tilly H; Valensi F; Troussard X; Varet B; Hermine O
Leukemia; 2004 Nov; 18(11):1924-5. PubMed ID: 15385943
[No Abstract] [Full Text] [Related]
2. Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes.
Yasukawa M; Yamauchi H; Azuma T; Takada K; Ishimura M; Fujita S
Eur J Haematol; 2002 Aug; 69(2):112-4. PubMed ID: 12366716
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes.
Bolam S; Orchard J; Oscier D
Br J Haematol; 1997 Oct; 99(1):158-61. PubMed ID: 9359516
[TBL] [Abstract][Full Text] [Related]
4. Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin.
Tchiknavorian X; Otto J; Pivot X; Arnaud MC; Schneider M; Thyss A
Hematol Cell Ther; 1999 Nov; 41(5):233-4. PubMed ID: 10651125
[No Abstract] [Full Text] [Related]
5. Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen.
Rocco S; Improta S; Sagristani M; Quirino AA; Nitrato Izzo G; Russolillo S; Polistina MT; Mastrullo L
Haematologica; 2004 Jun; 89(6 Suppl):ECR19. PubMed ID: 15194555
[No Abstract] [Full Text] [Related]
6. Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
Johnson SA; Owen RG; Oscier DG; Leblond V; Levy V; Jaeger U; Seymour JF
Clin Lymphoma; 2005 Mar; 5(4):294-7. PubMed ID: 15794869
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Zinzani PL; Stefoni V; Musuraca G; Tani M; Alinari L; Gabriele A; Marchi E; Pileri S; Baccarani M
Cancer; 2004 May; 100(10):2190-4. PubMed ID: 15139063
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes.
Lefrère F; Hermine O; Belanger C; François S; Tilly H; Lebas de La Cour JC; Valensi F; Varet B; Troussard X
Leukemia; 2000 Apr; 14(4):573-5. PubMed ID: 10764141
[TBL] [Abstract][Full Text] [Related]
9. The role of fludarabine in the treatment of follicular and mantle cell lymphoma.
Lenz G; Hiddemann W; Dreyling M
Cancer; 2004 Sep; 101(5):883-93. PubMed ID: 15329894
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
Niscola P; Palumbo R; Scaramucci L; Tendas A; Cupelli L; Giovannini M; Piccioni D; Dentamaro T; Perrotti AP; de Fabritiis P
Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
[No Abstract] [Full Text] [Related]
11. Blastic transformation of splenic lymphoma with villous lymphocytes after a well-controlled chronic phase of more than 10 years.
Kuwayama M; Machii T; Yamaguchi M; Yamaguti K; Kitani T; Kanakura Y
Int J Hematol; 2000 Feb; 71(2):167-71. PubMed ID: 10745627
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
Fujita T; Asagoe K; Sakoda H
Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
[TBL] [Abstract][Full Text] [Related]
13. Targeting base excision repair suggests a new therapeutic strategy of fludarabine for the treatment of chronic lymphocytic leukemia.
Bulgar AD; Snell M; Donze JR; Kirkland EB; Li L; Yang S; Xu Y; Gerson SL; Liu L
Leukemia; 2010 Oct; 24(10):1795-9. PubMed ID: 20811400
[No Abstract] [Full Text] [Related]
14. Splenic lymphoma with villous lymphocytes should be included in the differential diagnosis of massive splenomegaly.
Bedu-Addo G; Rutheford T; Bevan D; Bates I
Croat Med J; 1998 Dec; 39(4):412-8. PubMed ID: 9841942
[TBL] [Abstract][Full Text] [Related]
15. CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?
Bolaños-Meade J; Sarkodee-Adoo C; Khanwani SL
Am J Hematol; 2002 Oct; 71(2):139. PubMed ID: 12353319
[No Abstract] [Full Text] [Related]
16. [Splenic lymphoma with circulating hairy lymphocytes lymphoma. Clinical cytological study of 4 patients].
Jiménez S; Molero T; Santana C; Mataix R; Guerra L; Florensa L; Woessner S; Malcorra JJ
Sangre (Barc); 1995 Dec; 40(6):453-7. PubMed ID: 8850227
[TBL] [Abstract][Full Text] [Related]
17. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation influences response to therapy and prognosis.
Dungarwalla M; Appiah-Cubi S; Kulkarni S; Saso R; Wotherspoon A; Osuji N; Swansbury J; Cunningham DC; Catovsky D; Dearden CE; Matutes E
Br J Haematol; 2008 Oct; 143(1):71-4. PubMed ID: 18671706
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine in lymphoproliferative malignancies: a single-centre experience.
Prabhash K; Vikram GS; Nair R; Sengar M; Gujral S; Bakshi A; Gupta S; Parikh PM
Natl Med J India; 2008; 21(4):171-4. PubMed ID: 19267037
[TBL] [Abstract][Full Text] [Related]
19. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
[TBL] [Abstract][Full Text] [Related]
20. [Beneficial effect of interferon alfa-2a in a case of splenic lymphoma with circulating villous cells].
Ferrer Marco R; Ruiz Guinaldo MA; Martínez Martínez J; Navarro Gonzalo I
Sangre (Barc); 1993 Dec; 38(6):503-4. PubMed ID: 8171390
[No Abstract] [Full Text] [Related]
[Next] [New Search]
